
Meningococcemia is a bacterial infection with Neisseria meningitidis. This is one of many organisms that can infect the blood and the meninges (the tissues covering the brain and spinal cord). Blood infections caused by this bacteria without meningitis are called meningococcemia. Most cases occur during the winter and spring.
Meningococcemia is caused by an organism that usually lives harmlessly in the noses and throats of as much as 15 percent of the population. In a small number of individuals, the bacterium invades the bloodstream, causing collapse of the circulatory system.
Health experts aren't sure what suddenly sends the organism into the bloodstream, but they think respiratory distress or inflammation may begin the process.
The disease most commonly affects children under age 5, but anyone can get meningococcemia and it is more common in infants, children, and young adults. Nationally, about 3,000 people get the disease annually. Roughly one in 10 dies from it. An additional 10 percent are left with loss of hearing, mental retardation or amputations, usually of fingers or toes.
The disease spreads by contact with mucus or droplets from the nose and throat of an infected person. Many people carry the bacteria in their nose and throat without signs of illness, however.
The symptoms of the condition may appear suddenly, and often include fever, intense headache, stiff neck, nausea, and vomiting. Changes in behavior such as confusion, sleepiness, and being hard to wake up are important symptoms.
Symptoms may appear two to ten days after infection, but usually within three to four days.
A person can spread the disease as long as the bacteria are present in the nose or throat. After treatment, the bacteria usually disappear within 24 hours.
Probably not, though there are several types of N. meningitidis and infection with one type doesn't provide immunity to other types.
Patients are usually admitted to the intensive care unit of the hospital. Intensive monitoring and treatment are needed. Supportive measures for shock include:
Medications include intravenous (IV) aqueous penicillin for antibiotic therapy to eliminate the infection, and high doses of corticosteroids for shock (must be given early). Clotting factors or platelet replacement may be needed if bleeding disorders develop.
Other treatments include: wound care for thrombosed areas of the skin and respiratory isolation for first 24 hours.
Household members, playmates, and close friends of infected persons, or anyone who had saliva contact through kissing, sharing eating utensils, or drinking from the same glass, need to ask their doctor about antibiotics (single dose Ciprofloxin 500 mg. P.O. is recommended). People who have had casual contact as occurs in a classroom, office, or work setting, do not need treatment.
Anyone with a cold or influenza-like symptoms should be careful to cover their mouths and noses with tissue when sneezing or coughing.
Early treatment results in a good outcome. When shock develops, the outcome is more guarded. Profound shock, and adrenal collapse all predispose the patient to a poor prognosis with the possibility of death.
Note: This information is designed for educational purposes only and is not to be used as a substitute for professional medical advice.
| Antibiotic Safety |
| Community Acquired - MRSA |
| Hand Washing |
| Patient Safety |
| Speak Up Initiative - JCAHO |
| "Why Don't We Do It In Our Slevees?" |
| Hospital Main | (562) 997-2000 |
| Admitting | (562) 997-2100 |
| Business Office | (562) 256-8477 |
| Patient Relations | (562) 997-2513 |
| Family Health Clinic | (562) 997-2350 |
| Medical Records | (562) 997-2002 |
| Inpatient Pharmacy | (562) 997-2200 |
| Security | (562) 997-1420 |
| Transportation | (562) 256-8388 |
| Compliance Hotline | (877) 309-4925 |